Published in Cancer Weekly, October 11th, 1999
The results of this 14-year study, appearing in the Journal of Clinical Oncology's October 1999 issue, suggest that breast cancer patients who carry either the BRCA1 or BRCA2 gene may be at higher risk for late relapses than their counterparts who do not harbor these mutations.
"Previous studies have established that women with BRCA1 or BRCA2 genes have a very high rate of developing breast cancer," said Bruce G. Haffty, MD, associate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.